Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	1003	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	1267	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	1330	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	1331	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	1462	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	1885	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	1901	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	2000	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	2560	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	3382	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	3961	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-	4447	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	1010	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	1287	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	1422	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	1467	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	1615	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	1659	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2202	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2232	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2260	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2301	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2428	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2820	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2876	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2957	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	2973	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	3677	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	4510	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	4788	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	8812	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+	9105	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLYCOLITHOCHOLATE (CAS# 474-74-8 ); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y